Thursday, 08 Oct 2020 08:03 AM MYT
The drugmaker said its two-antibody cocktail helped reduce viral levels more than the single antibody treatment had in a prior study. The lower viral load was potentially tied to a reduction in Covid-19 symptoms, the company said. Several drugmakers are testing antibody treatments for Covid-19 as a means of helping patients' immune systems fight the virus. None of those drugs have been authorised for emergency use in the United States.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: